Sfoglia per Rivista DIABETES/METABOLISM RESEARCH AND REVIEWS
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI)
1999-01-01 Visalli, N; Cavallo, Mg; Signore, A; Baroni, Mg; Buzzetti, R; Fioriti, E; Mesturino, C; Fiori, R; Lucentini, L; Matteoli, Mc; Crino, A; Corbi, S; Spera, S; Teodonio, C; Paci, F; Amoretti, R; Pisano, L; Suraci, C; Multari, G; Sulli, N; Cervoni, M; De Mattia, G; Faldetta, Mrc; Boscherini, B; Bitti, Mlm; Marietti, G; Ferrazzoli, F; Bizzarri, C; Pitocco, D; Ghirlanda, G; Pozzilli, P
A tribute to Professor Domenico Andreani
2019-01-01 Pozzilli, P
Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure
2009-01-01 Chello, M; Spadaccio, C; Lusini, M; Covino, E; Blarzino, C; DE MARCO, F; DI DOMENICO, F; Coccia, R
Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
2017-01-01 Rizzo, P; Pitocco, D; Zaccardi, F; Di Stasio, E; Strollo, R; Rizzi, A; Scavone, G; Costantini, F; Galli, M; Tinelli, G; Flex, A; Caputo, S; Pozzilli, P; Landolfi, R; Ghirlanda, G; Nissim, A
Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk
2014-01-01 Soare, A; Weiss, Ep; Pozzilli, P
Blue eyes as a risk factor for type 1 diabetes
2011-01-01 Di Stasio, E; Maggi, D; Berardesca, E; Marulli, Gc; Bizzarri, C; Lauria, A; Portuesi, R; Cavallo, Mg; Costantino, F; Buzzetti, R; Astorri, E; Pitocco, D; Songini, M; Pozzilli, P; IMDIAB Group:, M Altomare; Astorri, E; Barchetta, I; Benevento, D; G Beretta Anguissola, ; Bizzarri, C; Buzzetti, R; Capizzi, M; Cappa, M; R Cassone Faldetta, M; G Cavallo, M; Cipolloni, L; Cipponeri, E; Costantino, F; Crinò, A; E Di Stasio, ; Fioriti, E; Ghirlanda, G; Guglielmi, C; Lauria, A; Maddaloni, E; Maggi, D; Manfrini, S; R Maurizi, A; Moretti, C; Morviducci, L; Napoli, N; R Nardone, M; Palermo, A; Patera, P; Pitocco, D; Portuesi, R; Scrocca, R; Spera, S; Strollo, R; Suraci, C; Tubili, C; Tuccinardi, D; Valente, L; Visalli, N
Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes
2001-01-01 Monetini, L; Cavallo, Mg; Stefanini, L; Ferrazzoli, F; Bizzarri, C; Marietti, G; Curro, V; Cervoni, M; Pozzilli, P
Challenges in developing endpoints for type 1 diabetes intervention studies
2009-01-01 Cernea, S; Raz, I; Herold, Kc; Hirshberg, B; Roep, Bo; Schatz, Da; Fleming, Ga; Pozzilli, P; Little, R; Schloot, Nc; Leslielo, Rdg; Skyler, Js; Palmer, Jp
Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies
2009-01-01 Khoo, Cp; Valorani, Mg; Brittan, M; Alison, Mr; Warnes, G; Johansson, U; Hawa, M; Pozzilli, P
Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
2016-01-01 Pozzilli, P; Battelino, T; Danne, T; Hovorka, R; Jarosz-Chobot, P; Renard, E
Diabetes classification: grey zones, sound and smoke: Action LADA 1
2008-01-01 Leslie, Rdg; Kolb, H; Schloot, Nc; Buzzetti, R; Mauricio, D; De Leiva, A; Yderstraede, K; Sarti, C; Thivolet, C; Hadden, D; Ter, S; Schernthaner, G; Scherbaum, W; Williams, R; Pozzilli, P
Diabetes in chronic liver disease: from old concepts to new evidence
2006-01-01 Picardi, A; D'Avola, D; VESPASIANI GENTILUCCI, U; Galati, G; Fiori, E; Spataro, S; Afeltra, A
Diabetes in chronic liver disease: from the old concepts to the most recent evidences
2006-01-01 Picardi, A; Davola, D; VESPASIANI GENTILUCCI, U; Galati, G; Fiori, E; Afeltra, A
Diabetes on demand and novel technologies
2018-01-01 Maurizi, A; Piemonte, V; Pozzilli, P
Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension
2019-01-01 Fuso, L; Pitocco, D; Antonelli Incalzi, R
Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: a preliminary study
1999-01-01 Beales, Pe; Burr, La; Webb, Gp; Mansfield, Kj; Pozzilli, P
DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19?
2020-01-01 Strollo, R; Pozzilli, P
Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012
2012-01-01 Roth, J; Pozzilli, P
Effect of diet on type 2 diabetes mellitus: a review
2014-01-01 Khazrai, Ym; Defeudis, G; Pozzilli, P
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes
2017-01-01 Guglielmi, C; Del Toro, R; Lauria, A; Maurizi, Ar; Fallucca, S; Cappelli, A; Angeletti, S; Lachin, Jm; Pozzilli, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI) | 1-gen-1999 | Visalli, N; Cavallo, Mg; Signore, A; Baroni, Mg; Buzzetti, R; Fioriti, E; Mesturino, C; Fiori, R; Lucentini, L; Matteoli, Mc; Crino, A; Corbi, S; Spera, S; Teodonio, C; Paci, F; Amoretti, R; Pisano, L; Suraci, C; Multari, G; Sulli, N; Cervoni, M; De Mattia, G; Faldetta, Mrc; Boscherini, B; Bitti, Mlm; Marietti, G; Ferrazzoli, F; Bizzarri, C; Pitocco, D; Ghirlanda, G; Pozzilli, P | |
A tribute to Professor Domenico Andreani | 1-gen-2019 | Pozzilli, P | |
Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure | 1-gen-2009 | Chello, M; Spadaccio, C; Lusini, M; Covino, E; Blarzino, C; DE MARCO, F; DI DOMENICO, F; Coccia, R | |
Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus. | 1-gen-2017 | Rizzo, P; Pitocco, D; Zaccardi, F; Di Stasio, E; Strollo, R; Rizzi, A; Scavone, G; Costantini, F; Galli, M; Tinelli, G; Flex, A; Caputo, S; Pozzilli, P; Landolfi, R; Ghirlanda, G; Nissim, A | |
Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk | 1-gen-2014 | Soare, A; Weiss, Ep; Pozzilli, P | |
Blue eyes as a risk factor for type 1 diabetes | 1-gen-2011 | Di Stasio, E; Maggi, D; Berardesca, E; Marulli, Gc; Bizzarri, C; Lauria, A; Portuesi, R; Cavallo, Mg; Costantino, F; Buzzetti, R; Astorri, E; Pitocco, D; Songini, M; Pozzilli, P; IMDIAB Group:, M Altomare; Astorri, E; Barchetta, I; Benevento, D; G Beretta Anguissola, ; Bizzarri, C; Buzzetti, R; Capizzi, M; Cappa, M; R Cassone Faldetta, M; G Cavallo, M; Cipolloni, L; Cipponeri, E; Costantino, F; Crinò, A; E Di Stasio, ; Fioriti, E; Ghirlanda, G; Guglielmi, C; Lauria, A; Maddaloni, E; Maggi, D; Manfrini, S; R Maurizi, A; Moretti, C; Morviducci, L; Napoli, N; R Nardone, M; Palermo, A; Patera, P; Pitocco, D; Portuesi, R; Scrocca, R; Spera, S; Strollo, R; Suraci, C; Tubili, C; Tuccinardi, D; Valente, L; Visalli, N | |
Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes | 1-gen-2001 | Monetini, L; Cavallo, Mg; Stefanini, L; Ferrazzoli, F; Bizzarri, C; Marietti, G; Curro, V; Cervoni, M; Pozzilli, P | |
Challenges in developing endpoints for type 1 diabetes intervention studies | 1-gen-2009 | Cernea, S; Raz, I; Herold, Kc; Hirshberg, B; Roep, Bo; Schatz, Da; Fleming, Ga; Pozzilli, P; Little, R; Schloot, Nc; Leslielo, Rdg; Skyler, Js; Palmer, Jp | |
Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies | 1-gen-2009 | Khoo, Cp; Valorani, Mg; Brittan, M; Alison, Mr; Warnes, G; Johansson, U; Hawa, M; Pozzilli, P | |
Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics | 1-gen-2016 | Pozzilli, P; Battelino, T; Danne, T; Hovorka, R; Jarosz-Chobot, P; Renard, E | |
Diabetes classification: grey zones, sound and smoke: Action LADA 1 | 1-gen-2008 | Leslie, Rdg; Kolb, H; Schloot, Nc; Buzzetti, R; Mauricio, D; De Leiva, A; Yderstraede, K; Sarti, C; Thivolet, C; Hadden, D; Ter, S; Schernthaner, G; Scherbaum, W; Williams, R; Pozzilli, P | |
Diabetes in chronic liver disease: from old concepts to new evidence | 1-gen-2006 | Picardi, A; D'Avola, D; VESPASIANI GENTILUCCI, U; Galati, G; Fiori, E; Spataro, S; Afeltra, A | |
Diabetes in chronic liver disease: from the old concepts to the most recent evidences | 1-gen-2006 | Picardi, A; Davola, D; VESPASIANI GENTILUCCI, U; Galati, G; Fiori, E; Afeltra, A | |
Diabetes on demand and novel technologies | 1-gen-2018 | Maurizi, A; Piemonte, V; Pozzilli, P | |
Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension | 1-gen-2019 | Fuso, L; Pitocco, D; Antonelli Incalzi, R | |
Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: a preliminary study | 1-gen-1999 | Beales, Pe; Burr, La; Webb, Gp; Mansfield, Kj; Pozzilli, P | |
DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? | 1-gen-2020 | Strollo, R; Pozzilli, P | |
Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012 | 1-gen-2012 | Roth, J; Pozzilli, P | |
Effect of diet on type 2 diabetes mellitus: a review | 1-gen-2014 | Khazrai, Ym; Defeudis, G; Pozzilli, P | |
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes | 1-gen-2017 | Guglielmi, C; Del Toro, R; Lauria, A; Maurizi, Ar; Fallucca, S; Cappelli, A; Angeletti, S; Lachin, Jm; Pozzilli, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile